- ASE Technology Holding Co, Ltd (NYSE:ASX) reported a first-quarter net revenue decline of 9% year-on-year to NT$130.89 billion. The revenue declined by 26% quarter-on-quarter.
- Net revenues for ATM (assembly, testing, and material) business was NT$73.32 billion, down by 13% Y/Y and 22% Q/Q.
- EMS (electronic manufacturing services) net revenues were NT$57.73 billion, down by 31% Q/Q.
- Gross margin decreased by 440 bps Q/Q to 14.8%.
- The operating margin declined by 520 bps Q/Q to 5.9%.
- Diluted EPS was NT$1.30 (or $0.086 per ADS).
- Capital expenditures totaled $231 million.
- Price Action: ASX shares traded higher by 0.59% at $6.85 on the last check Thursday.
Viking Therapeutics Earnings Preview
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement.
Analysts estimate that Viking Therapeutics will report an earnings per share (EPS) of $-0.21.
